{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:24:23Z","timestamp":1790267063375,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["FI20\/00090"],"award-info":[{"award-number":["FI20\/00090"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ICI20\/00131"],"award-info":[{"award-number":["ICI20\/00131"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"publisher","award":["FPI-UAM-2021"],"award-info":[{"award-number":["FPI-UAM-2021"]}],"id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015755","name":"CIBERehd","doi-asserted-by":"crossref","award":["IMP\/00009"],"award-info":[{"award-number":["IMP\/00009"]}],"id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s12325-022-02067-8","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T12:03:52Z","timestamp":1645531432000},"page":"1743-1753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers"],"prefix":"10.1007","volume":"39","author":[{"given":"Ana","family":"Casaj\u00fas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Zubiaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Campod\u00f3nico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00eda","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Navares-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Villapalos-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Soria-Chacartegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Novalbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Mej\u00eda-Abril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-8885","authenticated-orcid":false,"given":"Francisco","family":"Abad-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"2067_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/apt.13559","volume":"43","author":"W Moon","year":"2016","unstructured":"Moon W, Loftus EV. Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2016;43:863\u201383.","journal-title":"Aliment Pharmacol Ther"},{"key":"2067_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/FPC.0b013e328334338f","volume":"20","author":"G Zaza","year":"2010","unstructured":"Zaza G, Cheok M, Krynetskaia N, et al. Thiopurine pathway. Pharmacogenet Genom. 2010;20:573\u20134.","journal-title":"Pharmacogenet Genom"},{"key":"2067_CR3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.leukres.2007.09.015","volume":"32","author":"X-X Peng","year":"2008","unstructured":"Peng X-X, Shi Z, Damaraju VL, et al. Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine. Leuk Res. 2008;32:799\u2013809.","journal-title":"Leuk Res"},{"key":"2067_CR4","first-page":"143","volume":"10","author":"R Abaji","year":"2017","unstructured":"Abaji R, Krajinovic M. Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response. Pharmgenomics Pers Med. 2017;10:143\u201356.","journal-title":"Pharmgenomics Pers Med"},{"key":"2067_CR5","doi-asserted-by":"publisher","first-page":"175628482093742","DOI":"10.1177\/1756284820937426","volume":"13","author":"P Zalizko","year":"2020","unstructured":"Zalizko P, Stefanovics J, Sokolovska J, et al. Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population. Ther Adv Gastroenterol. 2020;13:175628482093742.","journal-title":"Ther Adv Gastroenterol"},{"key":"2067_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2174\/138920012803341311","volume":"13","author":"T Cabaleiro","year":"2012","unstructured":"Cabaleiro T, Roman MP, Gisbert J, Abad-Santos F. Utility of assessing thiopurine S-methyltransferase polymorphisms before azathioprine therapy. Curr Drug Metab. 2012;13:1277\u201393.","journal-title":"Curr Drug Metab"},{"key":"2067_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","volume":"118","author":"MC Dubinsky","year":"2000","unstructured":"Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705\u201313.","journal-title":"Gastroenterology"},{"key":"2067_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/clpt.2010.320","volume":"89","author":"MV Relling","year":"2011","unstructured":"Relling MV, Gardner EE, Sandborn WJ, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther. 2011;89:387\u201391.","journal-title":"Clin Pharmacol Ther"},{"key":"2067_CR9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/cpt.1304","volume":"105","author":"MV Relling","year":"2019","unstructured":"Relling MV, Schwab M, Whirl-Carrillo M, et al. Clinical Pharmacogenetics Implementation Consortium guideline for thiopurine dosing based on TPMT and NUDT 15 genotypes: 2018 update. Clin Pharmacol Ther. 2019;105:1095\u2013105.","journal-title":"Clin Pharmacol Ther"},{"key":"2067_CR10","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.3390\/jcm10173772","volume":"10","author":"P Zubiaur","year":"2021","unstructured":"Zubiaur P, Mej\u00eda-Abril G, Navares-G\u00f3mez M, et al. PriME-PGx: La Princesa University Hospital multidisciplinary initiative for the implementation of pharmacogenetics. J Clin Med. 2021;10:3772.","journal-title":"J Clin Med"},{"key":"2067_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fmed.2020.00008","volume":"7","author":"JS Cornish","year":"2020","unstructured":"Cornish JS, Wirthgen E, D\u00e4britz J. Biomarkers predictive of response to thiopurine therapy in inflammatory bowel disease. Front Med. 2020;7:8.","journal-title":"Front Med"},{"key":"2067_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/cpt.463","volume":"101","author":"C Liu","year":"2017","unstructured":"Liu C, Yang W, Pei D, et al. Genomewide approach validates thiopurine methyltransferase activity is a monogenic pharmacogenomic trait. Clin Pharmacol Ther. 2017;101:373\u201381.","journal-title":"Clin Pharmacol Ther"},{"key":"2067_CR13","doi-asserted-by":"crossref","unstructured":"Asadov C, Aliyeva G, Mustafayeva K. Thiopurine S-methyltransferase as a pharmacogenetic biomarker: significance of testing and review of major methods. Cardiovasc Hematol Agents Med Chem. 2017;15:23\u201330. http:\/\/www.eurekaselect.com\/152738\/article. Accessed 16 Nov 2021.","DOI":"10.2174\/1871525715666170529091921"},{"key":"2067_CR14","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.3748\/wjg.v20.i13.3475","volume":"20","author":"AJ Yarur","year":"2014","unstructured":"Yarur AJ, Abreu MT, Deshpande AR, Kerman DH, Sussman DA. Therapeutic drug monitoring in patients with inflammatory bowel disease. World J Gastroenterol. 2014;20:3475\u201384.","journal-title":"World J Gastroenterol"},{"key":"2067_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/medicina55080441","volume":"55","author":"DG Ribaldone","year":"2019","unstructured":"Ribaldone DG, Adriani A, Caviglia GP, et al. Correlation between thiopurine S-methyltransferase genotype and adverse events in inflammatory bowel disease patients. Medicina. 2019;55:441.","journal-title":"Medicina"},{"key":"2067_CR16","unstructured":"European Medical Agency. JAYEMPI- azathioprine drug label. 2021. https:\/\/www.ema.europa.eu\/en\/documents\/overview\/jayempi-epar-medicine-overview_es.pdf. Accessed 13 Nov 2021."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02067-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02067-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02067-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T11:41:17Z","timestamp":1649331677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02067-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02067-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"25 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}